Klacid: The safety of clarithromycin during pregnancy and breastfeeding of infants has not been established. Klacid should thus not be used during pregnancy or lactation unless the benefit is considered to outweigh the risk. Some animal studies have suggested an embryotoxic effect, but only at dose levels which are clearly toxic to mothers. Clarithromycin has been found in the milk of lactating animals and in human breast milk.
Controloc: Clinical experience in pregnant women is limited. There is no information on the excretion of pantoprazole into human breast milk. Controloc tablets should only be used when the benefit to the mother is considered greater than the potential risk to the fetus/baby.
Ospamox: There is no current evidence to suggest any embryotoxic, teratogenic or mutagenic effects of Ospamox during pregnancy. It should, however, be borne in mind that amoxicillin diffuses into breast milk.